During the past decade, Royal Albert Edward Infirmary conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Royal Albert Edward Infirmary" #1 sponsor was "Institute of Cancer Research, United Kingdom" with 4 trials, followed by "Royal Brompton & Harefield NHS Foundation Trust" with 2 trials sponsored, "University College, London" with 2 trials sponsored, "Cambridge University Hospitals NHS Foundation Trust" with 1 trials sponsored and "Cancer Research UK" with 1 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Royal Albert Edward Infirmary" #1 collaborator was "Cancer Research UK" with 2 trials as a collaborator, "Australian and New Zealand Intensive Care Research Centre" with 1 trials as a collaborator, "Berry Consultants" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Celgene" with 1 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 26 trials.

According to Clinical.Site data, the most researched conditions in "Royal Albert Edward Infirmary" are "Breast Cancer" (5 trials), "Colorectal Cancer" (3 trials), "Prostate Cancer" (3 trials), "Cancer" (2 trials) and "Abscess Anorectal" (1 trials). Many other conditions were trialed in "Royal Albert Edward Infirmary" in a lesser frequency.

Most popular intervention types in "Royal Albert Edward Infirmary" are "Drug" (10 trials), "Other" (7 trials), "Procedure" (6 trials), "Behavioral" (2 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Aromatase Inhibitors" (2 trials), "adjuvant therapy" (2 trials), "capecitabine" (2 trials), "ADT" (1 trials) and "ARB + DMX-200" (1 trials). Other intervention names were less common.

The vast majority of trials in "Royal Albert Edward Infirmary" are 18 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Royal Albert Edward Infirmary". undefined are not yet recruiting, 7 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Royal Albert Edward Infirmary, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Royal Albert Edward Infirmary, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".